Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPD

16 de mayo de 2017 actualizado por: Zhujiang Hospital

Effects of Combined Cycle Training and Inspiratory Muscle Training on Exercise Performance ,Health-related Quality,Dyspnoea ,Body Composition,Depressive Symptomatology in Patients With Chronic Obstructive Pulmonary Disease(COPD)

Chronic Obstructive Pulmonary Disease (COPD) ，the fourth leading cause of death in the world, represents an important public health challenge. It is also a major cause of chronic morbidity, mortality and disability throughout the world, leading to a heavy social and economic burden. For a long time, treatment of COPD mainly focus on drug therapy. Recently, pulmonary rehabilitation is recognized as a core component of the management of individuals with chronic respiratory disease, which has been clearly demonstrated to reduce dyspnea, increase exercise capacity, and improve quality of life.

Exercise training, widely regarded as the cornerstone of pulmonary rehabilitation , is one of the best available means of improving muscle function in COPD.The most commonly form is cycle training. Inspiratory Muscle Training (IMT) as an adjunct to exercise training has an additional benefit on inspiratory muscle strength, endurance and exercise capacity in patient with COPD.

There is insufficient evidence demonstrate greater benefits from combined inspiratory muscle training and cycle training. This study will evaluate the effects of combined inspiratory muscle training and cycle training in patients with COPD.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

The patients with COPD will participate in a rehabilitation program for 8 weeks. Participants in the proposed study will be randomly programmed into one of three intervention groups:

  1. Cycle training program alone (performing on calibrated stationary cycle ergometer).
  2. Combined cycle training and inspiratory muscle training(performing on calibrated stationary cycle ergometer and threshold loading device).
  3. Neither cycle training nor inspiratory muscle training.

Tipo de estudio

Intervencionista

Inscripción (Actual)

90

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

  • Porcelana
    • Guangdong
      • Guangzhou, Guangdong, Porcelana, 510282
        • Zhujiang Hospital,Southern Medical Universtiy

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

40 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patients between 40 and 75 years of age were eligible if they met the following criteria:

    • moderate to severe airflow obstruction (30≤ Forced Expiratory Volume At One Second(FEV1) <80% predicted and Forced Expiratory Volume At One Second/Forced Vital Capacity(FEV1/FVC)<70%)
    • Complaints of dyspnea on exertion
    • Clinically stable condition
    • No participation in a pulmonary rehabilitation program in the last year.

Exclusion Criteria:

  • Patients were excluded if they had evidence of asthma and/or had experienced a major exacerbation in the 2 months before enrollment
  • Required home oxygen therapy or experienced oxyhemoglobin desaturation below 85% with exercise
  • And/or had other health problems that would interfere with exercise.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Grupo de control
Ni entrenamiento de bicicleta ni entrenamiento de músculos inspiratorios.
Dispositivo: Grupo de control
Ni entrenamiento de bicicleta ni entrenamiento de músculos inspiratorios.
Experimental: Cycle training group
A 30-minute cycling training session is performed 3 days a week using calibrated cycle ergometer.
Dispositivo: calibrated cycle ergometer
The most common device to proform cycle training is calibrated cycle ergometer.
Experimental: Combined group
A 30-minute Combined training session is performed 3 days a week using calibrated cycle ergometer and threshold loading device.
Dispositivo: calibrated cycle ergometer and threshold loading device
Combined cycle training and inspiratory muscle training.The threshold loading device is composed of a mouth -piece attached to a small plastic cylinder that contains a spring-loaded poppet value. The valve opens to permit inspiratory flow only once the person has generated adequate negative intrathoracic pressure to condense the spring.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Exercise Performance (composite outcome measure)
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Exercise performance tests include field walking tests and cycle ergometer tests.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Health-related quality (composite outcome measure)
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Health-related quality is a component of the broader concept of quality of life and is defined as satisfaction with health.The St. George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Disease Questionnaire (CRQ）; and its self-reported version are the most widely used disease-specific questionnaires.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
inspiratory muscle function (composite outcome measure)
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Currently, a variety of methods can be used to evaluate respiratory muscle function, including maximal inspiratory (PImax)，expiratory pressures(PEmax) and inspiratory muscle endurance.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Symptom Evaluation (composite outcome measure)
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Individuals with chronic respiratory disease often have symptoms such as dyspnea, fatigue, cough, weakness, sleeplessness,and psychological distress.Instruments for assessment of multiple symptoms include COPD Assessment Test (CAT) and Modified Medical British Research Council Scale(mMRC).
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Depression and anxiety evaluation
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Hospital Anxiety and Depression Scale (HADS) was found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Composite outcomes
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Among patients with COPD there is increasing interest in the use of multidimensional indices to characterize the severity of the disease and better predict outcomes.Arguably the most well-known of these indices is the BODE Index.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Body Composition Monitor
Periodo de tiempo: The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)
Body composition abnormalities are prevalent in COPD.Human body composition analyzer can detect various elements of human body and analyze human health status.
The groups will be assessed at baseline (time zero) and at the end of the training protocol (week 8)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Zhujiang Hospital

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de diciembre de 2014

Finalización primaria (Actual)

1 de enero de 2017

Finalización del estudio (Actual)

1 de enero de 2017

Fechas de registro del estudio

Enviado por primera vez

20 de julio de 2014

Primero enviado que cumplió con los criterios de control de calidad

24 de julio de 2014

Publicado por primera vez (Estimar)

25 de julio de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de mayo de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

16 de mayo de 2017

Última verificación

1 de marzo de 2016

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • CX13902205193

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Grupo de control

Buscar ensayos similares

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

CROs by country

CROs in Croatia

Condiciones

Enfermedades Raras

Intervenciones de drogas

Suplementos dietéticos

Patrocinador / Colaboradores

Localizaciones

Suscribir